Synonym:
2-(Pyridine-3-carbonylamino)ethyl nitrate,
2-Nicotinamidoethyl nitrate,
Ikorel,
N-[2-(Nitrooxy)ethyl]-3-pyridinecarboxamide,
SG-75,
Sigmart,
Zynicor
Properties:
| Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards N - O,
Pharmacopeia & Metrological Institutes Standards
|
Description:
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia
.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the <A href="javascript:OpenWin('http://crs.edqm.eu/','height=400,width=600,scrollbars=yes,menubar=yes,resizable=1,toolbar=yes,status=yes')">EDQM reference substance catalogue</A>.
Biochem/physiol Actions
Nicorandil is a hybrid ATP-sensitive K+ (KATP) channel opener and nicotinamide nitrate NO donor. Nicorandil selectively activates SUR2B- versus SUR2A-containing KATP channels. It enhances endothelial NO synthase expression and protects against ischemic ventricular arrhythmias. By activating potassium channels, and donating nitric oxide to activate the enzyme guanylate cyclase, Nicorandil causes activation of GMP leading to both arterial and venous vasodilatation. Nicorandil is selective for vascular potassium channels, but has no significant action on cardiac contractility and conduction.
Safety:
Symbol


GHS05, GHS07
Hazard statements
H302-H318
Precautionary statements
P280-P301 + P312 + P330-P305 + P351 + P338 + P310
RIDADR
NONH for all modes of transport